Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

the placebo response for P2a was much much higher than 5.5% for moderate disease even. Maybe the larger numbers for P2b will be more in line with other trials. But much harder for leo to have good insight than one might expect if rates are higher for placebo. Also, i would bet he knows much more than we think about the data at this point and he says nothing that creates a buzz. Is his management style now really different? He always prefers to get positive info out there, most recent examples being group by group info for B UC and then the interim for B OM

no such leaks hints for P...

this bodes poorly for p prospects